2023
National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020
Lu Y, Liu Y, Dhingra L, Caraballo C, Mahajan S, Massey D, Spatz E, Sharma R, Rodriguez F, Watson K, Masoudi F, Krumholz H. National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020. JAMA Network Open 2023, 6: e2345964. PMID: 38039001, PMCID: PMC10692850, DOI: 10.1001/jamanetworkopen.2023.45964.Peer-Reviewed Original ResearchConceptsAtherosclerotic cardiovascular diseaseHistory of ASCVDCross-sectional studyLifestyle modificationPharmacological medicationsOptimal careCurrent careUS adultsEthnic differencesWhite individualsGuideline-recommended therapiesTotal cholesterol controlNon-Hispanic white individualsNutrition Examination SurveyLatino individualsQuality of careSelf-reported raceStatin useRecommended TherapiesSecondary preventionCholesterol controlOptimal regimensSmoking cessationEligible participantsExamination Survey
2018
Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States
Lu Y, Wang P, Zhou T, Lu J, Spatz ES, Nasir K, Jiang L, Krumholz HM. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States. Journal Of The American Heart Association 2018, 7: e007462. PMID: 29374046, PMCID: PMC5850247, DOI: 10.1161/jaha.117.007462.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntihypertensive AgentsAttitude of Health PersonnelBlood GlucoseBlood PressureBody Mass IndexCardiovascular DiseasesChinaDiabetes MellitusDyslipidemiasFemaleHealth Knowledge, Attitudes, PracticeHealth Status DisparitiesHumansHypertensionHypolipidemic AgentsLipidsLongitudinal StudiesMaleMiddle AgedNutrition SurveysObesityPractice Patterns, Physicians'PrevalencePrognosisRisk AssessmentRisk FactorsTime FactorsUnited StatesWaist CircumferenceConceptsHigher stroke prevalenceCardiovascular risk factorsHigh-sensitivity C-reactive proteinBody mass indexC-reactive proteinRisk factorsBlood pressureWaist circumferenceMass indexStroke prevalenceCardiovascular risk factor profileHigher mean blood pressureControl of hypertensionMean blood pressureBlood pressure levelsRisk factor profileComparison of prevalenceRepresentative population sampleLower ratesDyslipidemia awarenessSevere hypertensionHemoglobin A1cHypertension treatmentControl ratePlasma glucose
2017
Trends in Cardiovascular Health of US Adults by Income, 2005-2014
Beckman AL, Herrin J, Nasir K, Desai NR, Spatz ES. Trends in Cardiovascular Health of US Adults by Income, 2005-2014. JAMA Cardiology 2017, 2: 814-816. PMID: 28593300, PMCID: PMC5815082, DOI: 10.1001/jamacardio.2017.1654.Peer-Reviewed Original Research
2010
Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey
Spatz ES, Ross JS, Desai MM, Canavan ME, Krumholz HM. Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey. American Heart Journal 2010, 160: 115-121. PMID: 20598981, PMCID: PMC3025407, DOI: 10.1016/j.ahj.2010.04.013.Peer-Reviewed Original ResearchConceptsTreatment of hypertensionNutrition Examination SurveyInsurance statusMedication treatmentExamination SurveyNational HealthUsual sourceAdult Treatment Panel III recommendationsJoint National Committee 7Multivariable logistic regression modelingInsurance coverageSeparate multivariable modelsChronic disease managementLogistic regression modelingHigh-quality careRace/ethnicityCardiovascular diseaseMultivariable modelStratified analysisHypertensionHypercholesterolemiaRegular sourceCareDisease managementIndependent effects
2009
From Here to JUPITER
Spatz ES, Canavan ME, Desai MM. From Here to JUPITER. Circulation Cardiovascular Quality And Outcomes 2009, 2: 41-48. PMID: 20031811, DOI: 10.1161/circoutcomes.108.832592.Peer-Reviewed Original ResearchMeSH KeywordsAgedBiomarkersCardiovascular DiseasesC-Reactive ProteinEvidence-Based MedicineFemaleHealth SurveysHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsLipoproteins, LDLMaleMiddle AgedNutrition SurveysPatient SelectionPractice Guidelines as TopicRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTime FactorsConceptsHigh-sensitivity C-reactive proteinLow-density lipoproteinStatin therapyC-reactive proteinElevated high-sensitivity C-reactive protein levelsHigh-sensitivity C-reactive protein levelsElevated low-density lipoprotein levelsGoal low-density lipoproteinIntervention Trial Evaluating RosuvastatinC-reactive protein levelsOlder personsLow-density lipoprotein levelsUse of statinsNutrition Examination SurveyCardiovascular riskMetabolic syndromeLipoprotein levelsPrimary preventionExamination SurveyTreatment recommendationsNational HealthElderly adultsTherapyStatinsOlder adults